CEBP CTRC-AACR San Antonio Breast Cancer Symposium Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taioli, E.
Right arrow Articles by Hecht, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taioli, E.
Right arrow Articles by Hecht, S. S.

Cancer Epidemiology Biomarkers & Prevention, Vol 6, Issue 7 517-522, Copyright © 1997 by American Association for Cancer Research


ARTICLES

Effects of indole-3-carbinol on the metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokers

E Taioli, S Garbers, HL Bradlow, SG Carmella, S Akerkar and SS Hecht
New York University Medical Center, New York 10012, USA.

Indole-3-carbinol (I3C) is a component of the human diet, occurring as a conjugate in certain cruciferous vegetables. I3C protects against carcinogenesis in a variety of animal models by modifying carcinogen metabolism. In mice, I3C decreases lung tumor formation by the tobacco-specific nitrosamine 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by enhancing its hepatic clearance (M. A. Morse et al., Cancer Res., 50: 2613-2617, 1990). In this study, our goal was to determine whether I3C would have similar effects on NNK metabolism in smokers as it did in mice. Thirteen women took 400 mg of I3C on 5 consecutive days and maintained constant smoking habits during this period. Their urine was analyzed before and after the I3C treatment period for two metabolites of NNK: 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and its glucuronide (NNAL-Gluc). I3C treatment resulted in decreased levels of urinary NNAL, NNAL-Gluc, and NNAL plus NNAL-Gluc, and increased NNAL-Gluc:NNAL ratio in 10 of the 13 women. The mean decreases in NNAL (-0.27 +/- 0.09 pmol/mg creatinine, -23.4%) and NNAL plus NNAL-Gluc (-0.43 +/- 0.16 pmol/mg creatinine, -10.9%) were statistically significant as was the increase in NNAL-Gluc:NNAL ratio (1.1 +/- 0.5, 39.9%). These changes in urinary metabolites of NNK were consistent with those seen in mice treated with I3C and NNK; they suggest that I3C increased hepatic metabolism of NNK in our smokers. This is the first study to examine the effects of I3C on metabolism of an exogenous carcinogen in humans.


This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. H. Lubin, N. Caporaso, D. K. Hatsukami, A. M. Joseph, and S. S. Hecht
The Association of a Tobacco-Specific Biomarker and Cigarette Consumption and Its Dependence on Host Characteristics
Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1852 - 1857.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Weng, C. Fang, R. J. Turesky, M. Behr, L. S. Kaminsky, and X. Ding
Determination of the Role of Target Tissue Metabolism in Lung Carcinogenesis Using Conditional Cytochrome P450 Reductase-Null Mice
Cancer Res., August 15, 2007; 67(16): 7825 - 7832.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. Kassie, L. B. Anderson, R. Scherber, N. Yu, D. Lahti, P. Upadhyaya, and S. S. Hecht
Indole-3-carbinol Inhibits 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone Plus Benzo(a)pyrene-Induced Lung Tumorigenesis in A/J Mice and Modulates Carcinogen-Induced Alterations in Protein Levels
Cancer Res., July 1, 2007; 67(13): 6502 - 6511.
[Abstract] [Full Text] [PDF]


Home page
aacredbookHome page
S. S. Hecht
Tobacco Carcinogen Biomarkers: Old and New
Am. Assoc. Cancer Res. Educ. Book, April 1, 2005; 2005(1): 85 - 88.
[Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. S. Hecht, S. G. Carmella, P. M.J. Kenney, S.-H. Low, K. Arakawa, and M. C. Yu
Effects of Cruciferous Vegetable Consumption on Urinary Metabolites of the Tobacco-Specific Lung Carcinogen 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone in Singapore Chinese
Cancer Epidemiol. Biomarkers Prev., June 1, 2004; 13(6): 997 - 1004.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. S. Hecht
Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer
Carcinogenesis, June 1, 2002; 23(6): 907 - 922.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
J. W Lampe
Health effects of vegetables and fruit: assessing mechanisms of action in human experimental studies
Am. J. Clinical Nutrition, September 1, 1999; 70(3): 475S - 490.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1997 by the American Association for Cancer Research.